Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shivani N. Kamdar
Observed names:
Kamdar Shivani,
Kamdar, Shivani,
Kamdar, Shivani Nainesh,
Shivani Kamdar
Institution:
General Electric (Canada)
Observed institutions:
Mount Sinai Hospital,
Mount Sinai Hospital,
University of Toronto,
Lunenfeld-Tanenbaum Research Institute,
General Electric (Canada),
Sinai Health System
show all 6
ORCID:
0000-0003-2812-3865
Observed ORCID:
0000-0003-2812-3865
OpenAlex ID:
A5029133774
Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression
2019
·
Shivani Kamdar
, Ruth Isserlin
, et al.
·
Clinical Epigenetics
·
44
PDF
A urine-based DNA methylation assay, ProCUrE, to identify clinically significant prostate cancer
2018
·
Fang Zhao
, Ekaterina Olkhov-Mitsel
, et al.
·
Clinical Epigenetics
·
40
PDF
Investigating Urinary Circular RNA Biomarkers for Improved Detection of Renal Cell Carcinoma
2022
·
Madonna R. Peter
, Fang Zhao
, et al.
·
Frontiers in Oncology
·
30
PDF
Dynamic interplay between locus-specific DNA methylation and hydroxymethylation regulates distinct biological pathways in prostate carcinogenesis
2016
·
Shivani N. Kamdar
, Linh T. Ho
, et al.
·
Clinical Epigenetics
·
27
PDF
GBX2 Methylation Is a Novel Prognostic Biomarker and Improves Prediction of Biochemical Recurrence Among Patients with Prostate Cancer Negative for Intraductal Carcinoma and Cribriform Architecture
2018
·
Renu Jeyapala
, Andrea J. Savio
, et al.
·
European Urology Oncology
·
13
An integrative DNA methylation model for improved prognostication of postsurgery recurrence and therapy in prostate cancer patients
2019
·
Renu Jeyapala
, Shivani Kamdar
, et al.
·
Urologic Oncology Seminars and Original Investigations
·
12
Methylation Markers in Prostate Biopsies Are Prognosticators for Late Biochemical Recurrence and Therapy after Surgery in Prostate Cancer Patients
2019
·
Andrea J. Savio
, Shivani Kamdar
, et al.
·
Journal of Molecular Diagnostics
·
11
PDF
A novel methylated cell-free DNA marker panel to monitor treatment response in metastatic prostate cancer
2022
·
Madonna R Peter
, Misha Bilenky
, et al.
·
Epigenomics
·
8
Combining CAPRA-S With Tumor IDC/C Features Improves the Prognostication of Biochemical Recurrence in Prostate Cancer Patients
2022
·
Renu Jeyapala
, Shivani Kamdar
, et al.
·
Clinical Genitourinary Cancer
·
8
A 38-gene model comprised of key TET2-associated genes shows additive utility to high-risk prostate cancer cases in the prognostication of biochemical recurrence
2020
·
Shivani Kamdar
, Neil E. Fleshner
, et al.
·
BMC Cancer
·
4
PDF
Integrative Epigenomics of Prostate Cancer
2019
·
Madonna Peter
, Shivani Kamdar
, et al.
·
Elsevier eBooks
·
3
Venetoclax in Combination with Obinutuzumab in Previously Untreated Fit Patients with Chronic Lymphocytic Leukemia: A Canadian Cost-Utility Analysis
2025
·
Gijs van de Wetering
, Carolyn Owen
, et al.
·
PharmacoEconomics - Open
PDF
EE372 Cost-Effectiveness Analysis of Lenvatinib vs Key Comparators in First-Line Unresectable Hepatocellular Carcinoma in Canada
2025
·
Kerigo Ndirangu
, Shivani Kamdar
, et al.
·
Value in Health
Exploring Targets of TET2-mediated Methylation Reprogramming as Potential Therapeutic Targets and Discriminators of Prostate Cancer Progression
2021
·
Kamdar, Shivani Nainesh
·
TSpace (University of Toronto)
PDF
重要なtet2関連遺伝子から成る38遺伝子モデルは,生化学的再発の予後化における高リスク前立腺癌症例への付加的有用性を示す【jst・京大機械翻訳】
2020
·
Kamdar Shivani
, E Fleshner Neil
, et al.
·
BMC Cancer
Additional file 6 of A 38-gene model comprised of key TET2-associated genes shows additive utility to high-risk prostate cancer cases in the prognostication of biochemical recurrence
2020
·
Kamdar, Shivani
, Fleshner, Neil E.
, et al.
·
Figshare
Contributors
2019
·
S. Babichev
, Rashidah Baharuddin
, et al.
·
Elsevier eBooks
Additional file 2: of Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression
2019
·
Kamdar, Shivani
, Isserlin, Ruth
, et al.
·
Figshare
Additional file 9: of Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression
2019
·
Kamdar, Shivani
, Isserlin, Ruth
, et al.
·
Figshare
Additional file 7: of Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression
2019
·
Kamdar, Shivani
, Isserlin, Ruth
, et al.
·
Figshare
Additional file 13: of Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression
2019
·
Kamdar, Shivani
, Isserlin, Ruth
, et al.
·
Figshare
Additional file 10: of Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression
2019
·
Kamdar, Shivani
, Isserlin, Ruth
, et al.
·
Figshare
Additional file 14: of Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression
2019
·
Kamdar, Shivani
, Isserlin, Ruth
, et al.
·
Figshare
Additional file 19: of Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression
2019
·
Kamdar, Shivani
, Isserlin, Ruth
, et al.
·
Figshare
Additional file 1: of Dynamic interplay between locus-specific DNA methylation and hydroxymethylation regulates distinct biological pathways in prostate carcinogenesis
2016
·
Kamdar, Shivani
, Ho, Linh
, et al.
·
Figshare
Show more works
View as search
Works count:
54
Citation count:
200
H-index:
8
I10-index:
7
Year
Topic
Type
